Sort
46,585 grants matching “heart failure”
Epigenetics of Arteriosclerosis in African American Hypertensive Sibships
$425,062Jennifer Ann Smith · University Of Michigan At Ann Arbor · R01 · FY2019 · HL
Surgical Intramyocardial Angiogenesis in a Swine Model of Endothelial Dysfunction
$425,000Frank W Sellke · Beth Israel Deaconess Medical Center · R01 · FY2008 · HL
Role of Integrin-Linked Kinase in Heart Failure and Ischemic Injury
$425,000Anthony Rosenzweig · Beth Israel Deaconess Medical Center · R01 · FY2010 · HL
Role of Integrin-Linked Kinase in Heart Failure and Ischemic Injury
$425,000Anthony Rosenzweig · Beth Israel Deaconess Medical Center · R01 · FY2008 · HL
Novel Mechanisms of Cardiac Ion Channel Regulation
$425,000Robin Mark Shaw · Cedars-Sinai Medical Center · R01 · FY2017 · HL
Macrophages as effectors of cell therapy for heart failure
$425,000Geoffrey De Couto · Cedars-Sinai Medical Center · R01 · FY2019 · HL
FRET assay for in situ assessment of nucleolytic lysosomal cell death in Alzheimer's neurodegeneration
$425,000Vladimir V Didenko · Baylor College Of Medicine · R21 · FY2021 · AG
Macrophages as effectors of cell therapy for heart failure
$425,000Ahmed Ibrahim · Cedars-Sinai Medical Center · R01 · FY2023 · HL
Role of Integrin-Linked Kinase in Heart Failure and Ischemic Injury
$425,000Anthony Rosenzweig · Beth Israel Deaconess Medical Center · R01 · FY2007 · HL
Macrophages as effectors of cell therapy for heart failure
$425,000Ahmed Ibrahim · Cedars-Sinai Medical Center · R01 · FY2021 · HL
Novel Mechanisms of Cardiac Ion Channel Regulation
$425,000Robin Mark Shaw · Cedars-Sinai Medical Center · R01 · FY2015 · HL
Targeting myofibroblasts for heart repair
$425,000Young-Jae Nam · Vanderbilt University Medical Center · R01 · FY2019 · HL
Macrophages as effectors of cell therapy for heart failure
$425,000Ahmed Ibrahim · Cedars-Sinai Medical Center · R01 · FY2020 · HL
Protein carbamylation and uremic cardiomyopathy in chronic kidney disease
$425,000Anders Hayden Berg · Cedars-Sinai Medical Center · R01 · FY2019 · HL
Targeting myofibroblasts for heart repair
$425,000Young-Jae Nam · Vanderbilt University Medical Center · R01 · FY2022 · HL
Role of Integrin-Linked Kinase in Heart Failure and Ischemic Injury
$425,000Anthony Rosenzweig · Beth Israel Deaconess Medical Center · R01 · FY2009 · HL
Novel Mechanisms of Cardiac Ion Channel Regulation
$425,000Robin Mark Shaw · Cedars-Sinai Medical Center · R01 · FY2016 · HL
Macrophages as effectors of cell therapy for heart failure
$425,000Ahmed Ibrahim · Cedars-Sinai Medical Center · R01 · FY2022 · HL
Targeting myofibroblasts for heart repair
$425,000Young-Jae Nam · Vanderbilt University Medical Center · R01 · FY2020 · HL
Protein carbamylation and uremic cardiomyopathy in chronic kidney disease
$425,000Anders Hayden Berg · Cedars-Sinai Medical Center · R01 · FY2020 · HL
A New Non-Canonical Role for an Alternatively Translated Ion Channel Protein
$425,000Robin Mark Shaw · Cedars-Sinai Medical Center · R01 · FY2018 · HL
CD28/B7 Costimulation Blockade-Resistant Graft Rejection
$425,000Childrens Hospital Of Philadelphia · R01 · FY2004 · AI
Surgical Intramyocardial Angiogenesis in a Swine Model of Endothelial Dysfunction
$425,000Frank W Sellke · Beth Israel Deaconess Medical Center · R01 · FY2009 · HL
Novel Mechanisms of Cardiac Ion Channel Regulation
$425,000Robin Mark Shaw · Cedars-Sinai Medical Center · R01 · FY2018 · HL
CD28/B7 Costimulation Blockade-Resistant Graft Rejection
$425,000Children'S Hospital Of Philadelphia · R01 · FY2003 · AI